Free tool
Healthcare stocks
We cover 177 companies in the Healthcare sector. The median market value in the group is $2.06B. Across the group, the median move over the past trading day is +0.91%. 57% of the 167 with a 200-day average trade above it. Price change over the past year runs from −39.6% to +66.1% across the middle 80 percent of the group, with a median of −2.1%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
177 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% | Oct 29, 2026 |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% | Oct 13, 2026 |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% | Oct 29, 2026 |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% | Oct 29, 2026 |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% | Oct 27, 2026 |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% | Oct 30, 2026 |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% | Oct 30, 2026 |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% | Nov 3, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% | Oct 21, 2026 |
| NVO.WA | Novo Nordisk A/S | 175.12 PLN | −10.34% | −1.45% | −9.22% | Nov 4, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% | Nov 4, 2026 |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% | Oct 14, 2026 |
| GIS.DE | Gilead Sciences, Inc. | 126.78 EUR | +7.51% | +23.41% | +33.64% | Oct 29, 2026 |
| PFE.DE | Pfizer Inc. | 24.44 EUR | +10.09% | +18.44% | +22.96% | Nov 3, 2026 |
| DAP.DE | Danaher Corporation | 184.45 EUR | +4.06% | −5.68% | +6.90% | Oct 20, 2026 |
| VX1.DE | Vertex Pharmaceuticals Incorporated | 475.00 EUR | +10.21% | +23.55% | +41.64% | Nov 2, 2026 |
| BRM.DE | Bristol-Myers Squibb Company | 58.02 EUR | +3.74% | +28.56% | +50.84% | Oct 29, 2026 |
| IUI1.DE | Intuitive Surgical, Inc. | 318.75 EUR | +1.95% | −33.01% | −21.06% | Oct 20, 2026 |
| SYK.DE | Stryker Corporation | 282.40 EUR | −8.40% | −4.46% | +34.90% | Oct 29, 2026 |
| 2M6.DE | Medtronic plc | 78.54 EUR | +1.19% | −2.78% | +2.65% | Sep 1, 2026 |
| SNW.DE | Sanofi | 78.75 EUR | −1.46% | +0.80% | −2.82% | Oct 30, 2026 |
| SAN.PA | Sanofi | 78.74 EUR | −1.48% | +1.00% | −2.60% | Oct 30, 2026 |
| GSK.L | GSK plc | 1,905.50 GBP | −5.06% | +4.06% | +30.59% | Oct 28, 2026 |
| GS71.DE | GSK plc | 22.35 EUR | −4.49% | +7.86% | +34.79% | Oct 28, 2026 |
| A58.DE | Elevance Health, Inc. | 342.50 EUR | +2.03% | +13.81% | −19.30% | Oct 21, 2026 |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | 717.90 EUR | +25.00% | +8.96% | −5.91% | Oct 28, 2026 |
| CGN.DE | The Cigna Group | 237.40 EUR | −9.42% | +0.45% | −8.78% | Nov 5, 2026 |
| BSX.DE | Boston Scientific Corporation | 42.30 EUR | +3.18% | −47.52% | −53.11% | Oct 28, 2026 |
| 0QF.DE | Moderna, Inc. | 136.12 EUR | +181.04% | +417.17% | +550.51% | Nov 5, 2026 |
| BAYN.DE | Bayer Aktiengesellschaft | 49.26 EUR | +3.29% | +30.00% | +76.91% | Nov 3, 2026 |
| BAY.WA | Bayer Aktiengesellschaft | 210.50 PLN | +2.53% | +34.11% | +76.59% | Nov 3, 2026 |
| EWL.DE | Edwards Lifesciences Corporation | 77.24 EUR | +2.88% | +7.49% | +11.65% | Oct 29, 2026 |
| BOX.DE | Becton, Dickinson and Company | 168.80 EUR | +23.08% | +2.38% | +1.73% | Nov 5, 2026 |
| IX1.DE | IDEXX Laboratories, Inc. | 468.10 EUR | −2.09% | −17.59% | +17.97% | Nov 2, 2026 |
| 2U3.DE | Alcon Inc. | 62.62 EUR | +2.25% | −4.76% | −7.70% | Nov 10, 2026 |
| ILU.DE | Illumina, Inc. | 193.08 EUR | +13.91% | +69.73% | +129.80% | Oct 29, 2026 |
| DC4.DE | DexCom, Inc. | 77.60 EUR | +16.52% | +37.44% | +21.06% | Oct 29, 2026 |
| IDP.DE | Biogen Inc. | 190.12 EUR | +0.21% | +26.49% | +65.32% | Oct 29, 2026 |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | 204.00 EUR | −19.59% | −40.19% | −10.21% | Oct 29, 2026 |
| ZOE.DE | Zoetis Inc. | 65.74 EUR | −4.92% | −38.01% | −49.47% | Nov 3, 2026 |
| FRE.DE | Fresenius SE & Co. KGaA | 45.85 EUR | +2.98% | −1.28% | +1.64% | Nov 4, 2026 |
| 22UA.DE | BioNTech SE | 100.00 EUR | +23.08% | +21.29% | +14.09% | Nov 3, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | 194.30 EUR | +13.49% | −6.30% | +11.64% | Oct 22, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | 194.20 EUR | +13.30% | −7.09% | +11.32% | Oct 22, 2026 |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% | Nov 5, 2026 |
| GE9.DE | Genmab A/S | 294.20 EUR | +17.26% | +9.78% | −11.12% | Nov 5, 2026 |
| VIA.DE | Viatris Inc. | 14.27 EUR | −9.28% | +38.01% | +67.32% | Nov 5, 2026 |
| QS51.DE | Straumann Holding AG | 98.00 EUR | −5.77% | −3.14% | −1.10% | Oct 28, 2026 |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% | Oct 27, 2026 |
| COLO-B.CO | Coloplast A/S | 462.50 DKK | +6.22% | −12.68% | −20.60% | Nov 3, 2026 |
| CBHD.DE | Coloplast A/S | 61.54 EUR | +5.85% | −5.48% | +7.91% | Nov 3, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | 195.00 EUR | +9.92% | +0.74% | +21.79% | Oct 22, 2026 |
| ORNBV.HE | Orion Oyj | 80.80 EUR | −1.76% | +29.38% | +21.01% | Oct 28, 2026 |
| FME.DE | Fresenius Medical Care AG | 40.36 EUR | −7.39% | +4.49% | −2.61% | Nov 3, 2026 |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.53% | +10.68% | +1.80% | Nov 10, 2026 |
| AFW.DE | Align Technology, Inc. | 143.00 EUR | −6.14% | +7.68% | −54.37% | Oct 28, 2026 |
| ABVX.PA | ABIVAX Société Anonyme | 102.30 EUR | −5.63% | −11.04% | +48.91% | Sep 21, 2026 |
| KRK.WA | Krka, d. d. | 1,110.00 PLN | −2.63% | +29.07% | +30.59% | Nov 12, 2026 |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% | Nov 4, 2026 |
| ALK-B.CO | ALK-Abelló A/S | 208.80 DKK | −6.62% | −7.16% | +5.09% | Nov 17, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| HLUN-B.CO | H. Lundbeck A/S | 42.68 DKK | +1.19% | +2.35% | +8.99% | Nov 11, 2026 |
| HLUN-A.CO | H. Lundbeck A/S | 42.25 DKK | +16.39% | +18.14% | +29.71% | Nov 11, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| OBCK.DE | Ottobock SE & Co. KGaA | 60.40 EUR | +4.50% | +0.68% | +0.68% | Nov 12, 2026 |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% | Oct 23, 2026 |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% | Nov 4, 2026 |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% | Nov 5, 2026 |
| 22Z.DE | Zealand Pharma A/S | 43.35 EUR | +7.70% | −29.74% | −28.16% | Nov 12, 2026 |
| ZEAL.CO | Zealand Pharma A/S | 326.90 DKK | +7.15% | −28.95% | −25.94% | Nov 12, 2026 |
| VIRP.PA | Virbac SA | 329.00 EUR | −5.32% | −6.93% | −2.08% | Sep 17, 2026 |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% | Nov 4, 2026 |
| B72.DE | AtaiBeckley Inc. | 6.45 EUR | +2.38% | +88.27% | +59.69% | Nov 12, 2026 |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% | Nov 13, 2026 |
| EMEIS.PA | emeis Société anonyme | 13.80 EUR | −0.86% | −5.61% | +10.93% | Sep 23, 2026 |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% | Nov 13, 2026 |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% | Oct 29, 2026 |
| DMP.DE | Dermapharm Holding SE | 42.00 EUR | −1.98% | +8.95% | +27.27% | Nov 12, 2026 |
| GN.CO | GN Store Nord A/S | 94.54 DKK | −2.03% | −13.98% | −18.50% | Nov 5, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% | Sep 10, 2026 |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% | Sep 29, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% | Oct 22, 2026 |
| EMBLA.CO | Embla Medical hf. | 30.15 DKK | +5.05% | −5.78% | −6.94% | Oct 20, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.82% | −12.36% | −44.50% | Nov 12, 2026 |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% | Nov 6, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% | Oct 22, 2026 |
| DIA.WA | Diagnostyka S.A. | 167.60 PLN | +0.72% | −3.07% | −17.76% | Sep 10, 2026 |
| NOLA-B.ST | Nolato AB (publ) | 51.80 SEK | +6.91% | −10.27% | −7.00% | Oct 29, 2026 |
| RDC.DE | Redcare Pharmacy NV | 62.05 EUR | −10.46% | −6.06% | −23.82% | Oct 29, 2026 |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% | Nov 4, 2026 |
| GDS.PA | Ramsay Générale de Santé SA | 10.95 EUR | −0.45% | +17.24% | +9.50% | Oct 16, 2026 |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% | Oct 22, 2026 |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% | Oct 22, 2026 |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% | Sep 24, 2026 |
| IVA.PA | Inventiva S.A. | 4.09 EUR | +3.94% | +0.99% | −14.63% | Sep 25, 2026 |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | 14.70 EUR | +13.08% | +15.81% | +24.49% | Nov 5, 2026 |
| TTALO.HE | Terveystalo Oyj | 7.78 EUR | +4.29% | −16.20% | −22.31% | Oct 21, 2026 |
| GUBRA.CO | Gubra A/S | 402.40 DKK | +6.23% | −24.64% | +4.79% | Nov 6, 2026 |
| VETO.PA | Vetoquinol SA | 70.60 EUR | −3.29% | −16.35% | −6.37% | Sep 11, 2026 |
| EUZ.DE | Eckert & Ziegler SE | 13.18 EUR | −4.56% | −12.19% | −24.60% | Nov 12, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% | Oct 22, 2026 |
| DBV.PA | DBV Technologies S.A. | 2.53 EUR | +5.42% | −22.51% | +60.13% | Oct 28, 2026 |
| SYNSAM.ST | Synsam AB (publ) | 59.50 SEK | +5.50% | −7.98% | +5.66% | Nov 12, 2026 |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% | Oct 23, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% | Oct 21, 2026 |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% | Sep 23, 2026 |
| GNFT.PA | Genfit S.A. | 14.30 EUR | +5.30% | +172.38% | +310.45% | Sep 29, 2026 |
| APOTEA.ST | Apotea AB (publ) | 75.30 SEK | +1.41% | −16.05% | −26.38% | Nov 5, 2026 |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% | Oct 22, 2026 |
| UU8.F | Neurogene Inc. | 33.20 EUR | +21.17% | +29.18% | +165.60% | Nov 12, 2026 |
| EVT.DE | Evotec SE | 3.25 EUR | −6.22% | −41.07% | −45.75% | Nov 5, 2026 |
| EQS.PA | Equasens Société anonyme | 34.05 EUR | −1.02% | −24.08% | −25.98% | Sep 28, 2026 |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.70 SEK | +3.06% | −15.47% | −29.98% | Nov 3, 2026 |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% | Oct 23, 2026 |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% | Sep 8, 2026 |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% | Nov 5, 2026 |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% | Oct 28, 2026 |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% | Sep 29, 2026 |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% | Nov 6, 2026 |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% | Aug 31, 2026 |
| ALCLS.PA | Cellectis S.A. | 2.94 EUR | +16.59% | −30.30% | +27.74% | Nov 13, 2026 |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% | Oct 22, 2026 |
| ILM1.DE | Medios AG | 10.92 EUR | −1.62% | −25.61% | −26.32% | Nov 10, 2026 |
| SBS.DE | Stratec SE | 22.85 EUR | +11.46% | +3.39% | −16.91% | Nov 12, 2026 |
| VICO.ST | Vicore Pharma Holding AB (publ) | 10.74 SEK | −0.74% | −2.19% | −1.29% | Nov 5, 2026 |
| PIHLIS.HE | Pihlajalinna Oyj | 10.92 EUR | +5.61% | −21.46% | −28.38% | Oct 28, 2026 |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% | Nov 12, 2026 |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% | Aug 28, 2026 |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% | Sep 29, 2026 |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% | Sep 17, 2026 |
| NORDH.OL | Nordhealth AS | 24.40 NOK | 0.00% | −32.22% | −32.22% | Nov 10, 2026 |
| ORIOLA.HE | Oriola Oyj | 0.90 EUR | −0.33% | −20.66% | −21.98% | Oct 29, 2026 |
| ALCGM.PA | Cegedim SA | 10.26 EUR | +1.38% | −25.92% | −4.56% | Sep 24, 2026 |
| PHO.OL | Photocure ASA | 54.00 NOK | −0.18% | −24.90% | −13.46% | Oct 28, 2026 |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% | Nov 11, 2026 |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% | Oct 22, 2026 |
| MVIR.ST | Medivir AB (publ) | 2.08 SEK | +14.29% | +351.19% | +4.73% | Nov 5, 2026 |
| AZT.OL | ArcticZymes Technologies ASA | 20.80 NOK | +5.05% | −1.89% | −27.02% | Nov 5, 2026 |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.70 SEK | −12.97% | −47.45% | −60.78% | Nov 3, 2026 |
| NANOFH.HE | Nanoform Finland Oyj | 0.96 EUR | +9.34% | −18.64% | +15.66% | Nov 11, 2026 |
| NANOFS.ST | Nanoform Finland Oyj | 10.94 SEK | +15.40% | −15.06% | +19.56% | Nov 11, 2026 |
| VISTN.OL | Vistin Pharma ASA | 19.15 NOK | −5.67% | −1.74% | −15.42% | Oct 29, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% | Sep 28, 2026 |
| ZLNA.OL | Zelluna ASA | 21.70 NOK | −2.25% | +55.00% | +56.57% | Nov 5, 2026 |
| SEZI.ST | Senzime AB (publ) | 3.78 SEK | +3.28% | −30.35% | −39.98% | Oct 29, 2026 |
| FLUO.ST | FluoGuide A/S | 33.40 SEK | +6.71% | −9.49% | −18.34% | Nov 26, 2026 |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% | Oct 22, 2026 |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% | Nov 25, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% | Aug 28, 2026 |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% | Oct 22, 2026 |
| OSSD.ST | OssDsign AB (publ) | 4.00 SEK | −10.01% | −64.60% | −73.26% | Nov 3, 2026 |
| OPTOMED.HE | Optomed Oyj | 1.71 EUR | +6.36% | −54.99% | −54.39% | Nov 6, 2026 |
| IVACC.ST | Intervacc AB (publ) | 1.10 SEK | −14.11% | +17.98% | +4.78% | Nov 12, 2026 |
| NAVA.OL | Navamedic ASA | 14.90 NOK | −8.31% | −35.22% | −32.27% | Oct 29, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% | Sep 10, 2026 |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | 1.03 EUR | +0.39% | −11.21% | −19.22% | Sep 15, 2026 |
| VIVE.ST | Vivesto AB | 8.90 SEK | +3.01% | −21.10% | −57.13% | Nov 12, 2026 |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | 1.38 SEK | −0.36% | −91.79% | −93.99% | Nov 12, 2026 |
| 6IV.DE | Inventiva S.A. | 4.08 EUR | +3.68% | +0.87% | −33.03% | Sep 25, 2026 |
| ADXN.SW | Addex Therapeutics Ltd | 0.03 CHF | −37.38% | −51.32% | −55.21% | Sep 14, 2026 |
| ALC.SW | Alcon Inc. | 58.72 CHF | +2.77% | −7.14% | −7.46% | Nov 10, 2026 |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% | Oct 23, 2026 |
| EVT.SW | Evotec SE | 3.15 CHF | −32.01% | −45.89% | −45.89% | Nov 5, 2026 |
| IDIA.SW | Idorsia Ltd | 5.68 CHF | −13.09% | +39.78% | +108.64% | Oct 29, 2026 |
| IMP-A-SDB.ST | Implantica AG | 58.00 SEK | −1.69% | +12.19% | −20.44% | Nov 19, 2026 |
| MOVE.SW | Medacta Group SA | 127.40 CHF | −7.55% | −18.95% | −10.60% | Sep 9, 2026 |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% | Oct 27, 2026 |
| RDC.SW | Redcare Pharmacy NV | 58.10 CHF | −7.92% | −4.75% | −4.75% | Oct 29, 2026 |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% | Nov 12, 2026 |
| STMN.SW | Straumann Holding AG | 91.54 CHF | −10.52% | −1.85% | −2.20% | Oct 28, 2026 |
| YPSN.SW | Ypsomed Holding AG | 407.20 CHF | +4.36% | +24.15% | +4.01% | Nov 11, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.